Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001213900-26-050436
Filing Date
2026-04-30
Accepted
2026-04-30 17:28:37
Documents
5

Document Format Files

Seq Description Document Type Size
1 PROXY STATEMENT ea0287703-04.htm DEFA14A 38755
2 GRAPHIC tproxy_001.jpg GRAPHIC 1435934
3 GRAPHIC tproxy_002.jpg GRAPHIC 1473678
4 GRAPHIC tproxy_003.jpg GRAPHIC 1951566
5 GRAPHIC tproxy_004.jpg GRAPHIC 2074144
  Complete submission text file 0001213900-26-050436.txt   9592531
Mailing Address 24 SCHOOL ST., 2ND FLOOR BOSTON MA 02108
Business Address 24 SCHOOL ST., 2ND FLOOR BOSTON MA 02108 401-426-4664
Allarity Therapeutics, Inc. (Filer) CIK: 0001860657 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-41160 | Film No.: 26927432
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)